Sagimet Biosciences

Sagimet stock doubles as phase 2b MASH trial hits primary goals, despite dropout queries
Fierce Biotech
Mon, 01/22/24 - 11:06 am
Sagimet Biosciences
clinical trials
MASH
NASH
denifanstat
How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Medical Marketing and Media
Sun, 07/23/23 - 12:42 pm
Sagimet Biosciences
IPOs
compliance
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
Tue, 07/18/23 - 11:34 am
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
NASH
clinical trials
89Bio
Arrowhead Pharmaceuticals
Can-Fite BioPharma
Ewopharma
Hepagene Therapeutics
JNJ
Ligand Pharmaceuticals
Madrigal Pharmaceuticals
Merck
NGM Biopharmaceuticals
NorthSea Therapeutics
Novartis
Sagimet Biosciences
Terns Pharmaceuticals
Viking Therapeutics
Going...going...gone. A small biotech throws in its IPO cards after market meltdown
Endpoints
Mon, 03/21/22 - 10:22 pm
Sagimet Biosciences
IPOs
NASH
3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq
Fierce Biotech
Mon, 04/19/21 - 11:08 am
IPOs
NASDAQ
Talaris Therapeutics
Gyroscope Therapeutics
Sagimet Biosciences